封面
市場調查報告書
商品編碼
1672723

內分泌檢測產品市場:依產品類型、技術、適應症、最終用戶和地區分類

Endocrine Testing Product Market, By Product Type, By Technology, By Disease Indication, By End User, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 208 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球內分泌檢測產品市場規模估計為 149.8 億美元,預計到 2032 年將達到 281.1 億美元,2025 年至 2032 年的複合年成長率為 9.4%。

報告範圍 報告詳細資訊
基準年 2024 2025 年市場規模 149.8億美元
效能資料 2020-2024 預測期 2025-2032
預測期:2025 年至 2032 年複合年成長率 9.40% 2032 年金額預測 281.1億美元
圖。
內分泌檢測產品市場-IMG1

內分泌檢測產品是用於檢測內分泌系統功能的體外診斷產品。內分泌系統是由腺體組成的調節系統,腺體直接分泌荷爾蒙進入血液循環,以調節遠處的目標器官。內分泌測試產品可幫助醫生監測荷爾蒙水平並篩檢內分泌失調。常見的內分泌檢查有甲狀腺功能檢查、睪固酮檢查、雌激素檢查、催乳素檢查、皮質醇檢查、胰島素檢查等。糖尿病、甲狀腺疾病和荷爾蒙失調等內分泌相關疾病的盛行率不斷上升,可能會推動全球對內分泌檢測的需求。診斷技術的進步促進了高靈敏度生物檢測和自動化解決方案的開發,可用於臨床實驗室的高性能內分泌測試。

市場動態

全球內分泌檢測產品市場的成長得益於老年人口的增加,老年人更容易患上內分泌疾病,對內分泌疾病的認知和篩檢不斷增加,以及內分泌功能測試在疾病診斷和管理中的應用不斷擴大。然而,新產品核可的漫長而複雜的監管過程以及不願修改現有測試程序可能會阻礙市場的成長。市場看到了從先進的免疫檢測平台的開發中獲得的豐厚機會,這些平台具有更高的準確性、更高的測試量和整合的資訊學。這樣就可以使用小樣本同時測試多種荷爾蒙。

研究的主要特點

本報告對全球內分泌檢測產品市場進行了詳細分析,並以 2024 年為基準年,展示了預測期(2025-2032 年)的市場規模(十億美元)和年複合成長率(CAGR%)。

它還強調了各個領域的潛在商機並說明了該市場的有吸引力的投資提案矩陣。

它還提供了對市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景以及主要企業採用的競爭策略的重要見解。

全球內分泌檢測產品市場的主要企業已根據公司亮點、產品系列、關鍵亮點、性能和策略等參數進行了分析。

研究涉及的主要企業包括雅培、AB Sciex、安捷倫科技公司、bioMerieux SA、Bio-Rad Laboratories Inc.、DiaSorin SpA、F. Hoffmann-La Roche Ltd.、Quest Diagnostics Inc.、丹納赫、Immunodiagnostic Systems 和 Fujirebio, Inc.

本報告的見解將使負責人和企業經營團隊能夠就未來產品發布、新興趨勢、市場擴張和行銷策略做出明智的決策。

全球內分泌檢測產品市場報告迎合了該行業的各個相關人員,例如投資者、供應商、產品製造商、經銷商、新進業者和金融分析師。

相關人員將透過全球內分泌檢測產品市場分析中使用的各種策略矩陣更輕鬆地做出決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 影響分析
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購情景
  • 流行病學
  • 管道分析

4. 內分泌檢測產品市場依產品類型分類,2020-2032 年(十億美元)

  • 介紹
  • 儀器/分析設備
  • 耗材

5. 內分泌檢測產品市場(依技術分類),2020-2032 年(十億美元)

  • 介紹
  • 液相層析法質譜法
  • 免疫檢測
  • 串聯式質譜質譜法
  • 感測器技術
  • 其他

6. 內分泌檢測產品市場(依疾病適應症分類),2020-2032 年(十億美元)

  • 介紹
  • 腎上腺功能不全和愛迪生氏症
  • 骨病
  • 癌症
  • 甲狀腺疾病
  • 其他

7. 內分泌檢測產品市場(以最終用戶分類),2020-2032 年(十億美元)

  • 介紹
  • 醫院
  • 臨床實驗室
  • 其他

8. 內分泌檢測產品市場,按地區,2020-2032 年(十億美元)

  • 介紹
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 亞太地區
  • 中東
  • 非洲

第9章 競爭格局

  • Abbott
  • AB Sciex
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin SpA
  • F.Hoffmann-La Roche Ltd.
  • Quest Diagnostics Inc
  • Danaher
  • Immunodiagnostic Systems
  • Fujirebio, Inc.

第 10 章分析師建議

  • 興衰
  • 一致的機會地圖

第 11 章 參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI1755

Global Endocrine Testing Product Market is estimated to be valued at USD 14.98 Bn in 2025 and is expected to reach USD 28.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.4% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 14.98 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 9.40% 2032 Value Projection: USD 28.11 Bn
Figure. Endocrine Testing Product Market Share (%), By Region 2025
Endocrine Testing Product Market - IMG1

Endocrine testing product refers to in vitro diagnostics that are used to test the functionality of the endocrine system. Endocrine system is a regulatory system composed of glands that secrete hormones directly into the circulatory system to regulate distant target organs. Endocrine testing products help physicians monitor hormone levels and screen for endocrine disorders. Some common endocrine tests include thyroid function tests, testosterone testing, estrogen testing, prolactin testing, cortisol testing, and insulin testing. Rising prevalence of endocrine-related diseases such as diabetes, thyroid disorders, and hormonal imbalance disorders can boost demand for endocrine testing worldwide. Advancements in diagnostic technologies have enabled the development of sensitive bioassays and automated solutions for high-throughput endocrine testing in clinical laboratories.

Market Dynamics

Global endocrine testing product market growth is driven by growing geriatric population who are more prone to developing endocrine disorders, increasing awareness and screening of endocrine conditions, and expanding applications of endocrine function tests in disease diagnosis and management. However, lengthy and complex regulatory processes for new product approvals and reluctance to change existing testing procedures can hamper the market growth. The market witness lucrative opportunities from the development of advanced immunoassay platforms with improved accuracy, high test volumes per run, and integrated informatics. This allows for the testing of multiple hormones simultaneously using small sample volumes.

Key Features of the Study

This report provides in-depth analysis of the global endocrine testing product market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global endocrine testing product market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Abbott, AB Sciex, Agilent Technologies Inc., bioMerieux SA, Bio-Rad Laboratories Inc., DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Quest Diagnostics Inc, Danaher, Immunodiagnostic Systems, and Fujirebio, Inc.

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global endocrine testing product market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global endocrine testing product market

Market Segmentation

  • By Product Type Insights
    • Instruments/Analyzers
    • Consumables
  • By Technology Insights
    • Liquid Chromatography-Mass Spectrometry
    • Immunoassay
    • Tandem Mass Spectroscopy
    • Sensor Technology
    • Others
  • By Disease Indication Insights
    • Adrenal Insufficiency and Addison Disease
    • Bone Disorders
    • Cancer
    • Thyroid Disease
    • Others
  • By End User Insights
    • Hospitals
    • Clinical Laboratories
    • Others
  • Regional Insights
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Abbott
    • AB Sciex
    • Agilent Technologies Inc.
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • DiaSorin S.p.A.
    • F. Hoffmann-La Roche Ltd.
    • Quest Diagnostics Inc
    • Danaher
    • Immunodiagnostic Systems
    • Fujirebio, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Endocrine Testing Product Market, By Product Type
    • Endocrine Testing Product Market, By Technology
    • Endocrine Testing Product Market, By Disease Indication
    • Endocrine Testing Product Market, By End User
    • Endocrine Testing Product Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Epidemiology
  • Pipeline Analysis

4. Endocrine Testing Product Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Instruments/Analyzers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Consumables
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Endocrine Testing Product Market, By Technology, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Liquid Chromatography-Mass Spectrometry
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Immunoassay
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tandem Mass Spectroscopy
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sensor Technology
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Endocrine Testing Product Market, By Disease Indication, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adrenal Insufficiency and Addison Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Bone Disorders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cancer
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Thyroid Disease
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Endocrine Testing Product Market, By End User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Clinical Laboratories
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Endocrine Testing Product Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025,2028 & 2032, (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • U.S.
    • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Technology, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Disease Indication, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

9. Competitive Landscape

  • Abbott
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • AB Sciex
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Agilent Technologies Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • bioMerieux SA
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bio-Rad Laboratories Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • DiaSorin S.p.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • F.Hoffmann-La Roche Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Quest Diagnostics Inc
  • Danaher
  • Immunodiagnostic Systems
  • Fujirebio, Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About us